Hyponatremia in Cirrhosis: Low Sodium Reflects Excess Water, Not Sodium Deficiency: AASLD Clinical Pearls | August 2026

Introduction:

Hyponatremia is common in advanced cirrhosis, particularly in patients with ascites, and reflects impaired free-water excretion due to effective arterial underfilling rather than true sodium depletion in most cases. Splanchnic vasodilation activates the RAAS, sympathetic nervous system, and non-osmotic ADH release, leading to sodium retention, water retention, and dilutional hyponatremia.

Why is this clinically important?

Hyponatremia often reflects advanced circulatory dysfunction in cirrhosis.

Correct classification into hypovolemic, euvolemic, or hypervolemic hyponatremia is essential because management differs.

Patients with cirrhosis are particularly vulnerable to osmotic demyelination syndrome (ODS) from overly rapid correction.

Hyponatremia carries important prognostic implications and is incorporated into MELD-Na.

Key Takeaways:

First confirm true hypotonic hyponatremia with serum osmolality <275 mOsm/kg.

Urine osmolality >100 mOsm/kg generally indicates ADH-mediated water retention.

In hypervolemic cirrhosis, urine sodium is typically low because the kidney senses reduced effective arterial blood volume.

Hypovolemic hyponatremia commonly results from overdiuresis, lactulose-associated diarrhea, vomiting, or volume loss after paracentesis.

Hypovolemic patients should generally receive volume replacement with crystalloid or albumin and have contributing diuretics/laxatives reduced or held.

Hypervolemic hyponatremia is managed with fluid restriction, adjustment of diuretics, and treatment of the underlying circulatory dysfunction.

Vaptans can raise serum sodium but have transient effects and are generally reserved for selected situations rather than routine long-term therapy.

Acute symptomatic hyponatremia may require 3% hypertonic saline, targeting an initial rise of about 4–6 mEq/L.

Cirrhosis is a high-risk state for ODS; chronic sodium correction should generally be limited to 4–6 mEq/L/day and not exceed 8 mEq/L in 24 hours.

Alcohol use, malnutrition, and hypokalemia further increase ODS risk.

Hyponatremia is associated with hepatic encephalopathy, spontaneous bacterial peritonitis, hepatorenal syndrome, and increased mortality.

The prognostic importance of serum sodium is why it became part of liver-transplant allocation through MELD-Na.

Clinical Impact:

The key practical principle is to treat the physiology, not simply the sodium number. In cirrhosis, correcting volume status, reviewing diuretics and lactulose, assessing renal function, and determining whether the patient is hypo- or hypervolemic are more important than reflexively administering saline.

Bottom Line:

Hyponatremia in cirrhosis is usually a marker of severe circulatory dysfunction and excess free-water retention. Correct the underlying volume problem carefully, avoid rapid sodium correction, and recognize low sodium as an important marker of decompensation and poor prognosis.